Cargando…

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

The activation of signaling pathways induced by Toll-like receptor (TLR) has been demonstrated to play essential roles in multiple liver diseases. Toll-interacting protein (Tollip) acts as an endogenous negative modulator of TLR signaling and is implicated in various cardio-metabolic diseases. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Lu, Yang, Qiong, Chen, Huihong, Wang, Zhenggeng, Liu, Qi, Ai, Shuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976180/ https://www.ncbi.nlm.nih.gov/pubmed/35434373 http://dx.doi.org/10.1515/med-2022-0453

Ejemplares similares

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Tollip or Not Tollip: What Are the Evolving Questions behind It?
por: Luiz, Denis Prudencio, et al.
Publicado: (2014)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

Up-Regulation of RACGAP1 Promotes Progressions of Hepatocellular Carcinoma Regulated by GABPA via PI3K/AKT Pathway
por: Gu, Yang, et al.
Publicado: (2022)

Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
por: Liu, Xin, et al.
Publicado: (2023)

TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway
por: Huang, Tao, et al.
Publicado: (2019)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway
por: Liu, Yachong, et al.
Publicado: (2022)

Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway
por: Zhang, Hua, et al.
Publicado: (2018)

CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway
por: Cheng, Rui, et al.
Publicado: (2020)

MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
por: Zhang, Zhenyu, et al.
Publicado: (2018)

Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway
Publicado: (2020)

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
por: Han, Wei, et al.
Publicado: (2022)

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway
por: Pu, Zhangya, et al.
Publicado: (2022)

MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K‐AKT‐β‐catenin pathways
por: Xie, Lulu, et al.
Publicado: (2019)

Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Liao, Junbin, et al.
Publicado: (2019)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
por: Luo, Xiangyuan, et al.
Publicado: (2021)

MicroRNA‐155‐5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway
por: Fu, Xiao, et al.
Publicado: (2017)

CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway
por: Zhou, Yan, et al.
Publicado: (2022)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

Overexpression of Rab40b Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway
por: Shi, Li-Wei, et al.
Publicado: (2020)

Epithelial V‐like antigen 1 promotes hepatocellular carcinoma growth and metastasis via the ERBB‐PI3K‐AKT pathway
por: Ni, QianZhi, et al.
Publicado: (2020)

Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway
por: Zhuang, Juhua, et al.
Publicado: (2018)

FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway
por: Wang, Baolin, et al.
Publicado: (2021)

YBX1 promotes tumor progression via the PI3K/AKT signaling pathway in laryngeal squamous cell carcinoma
por: Zhao, Jing, et al.
Publicado: (2021)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
por: Chen, Huarong, et al.
Publicado: (2019)

Apoptotic Effects of Xanthium strumarium via PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma
por: Kim, Juyoung, et al.
Publicado: (2019)

GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway
por: Chen, Rong, et al.
Publicado: (2023)

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN
por: Lin, Hui, et al.
Publicado: (2018)

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway
por: Chen, Han, et al.
Publicado: (2020)

Derlin-1 Promotes the Progression of Human Hepatocellular Carcinoma via the Activation of AKT Pathway
por: Fan, Jiye, et al.
Publicado: (2020)

Tollip Is a Mediator of Protein Sumoylation
por: Ciarrocchi, Alessia, et al.
Publicado: (2009)

LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway
por: Liu, Chunfeng, et al.
Publicado: (2019)

miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
por: Xu, Fen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h828frodt7e6d8jbdctadkmh01